Pfizer Inc at Truist Securities Life Sciences Summit (May Series) Transcript
Hello, everyone. I'm Gregg Gilbert. I cover pharmaceuticals here at Truist. I'm fortunate to be hosting this next fireside, next to Chuck's fireplace with Pfizer.
Before we begin, I need to read the following disclaimer. This call is arranged by Truist Securities Research, released by institutional investors and issuer clients, as defined by FINRA. If you are not an institutional investor or issuer, please disconnect at this time. For required disclosures, please see our website at truistsecurities.com or our equity research library.
For this next fireside, we have with us Chuck Triano, who's Pfizer's Senior Vice President and Head of IR. Chuck, thank you for joining me, and thanks to our Truist investor clients that are following along now or later.
Questions & Answers
So Chuck, I can't believe it was over 20 years ago when we met. You were new to in-house IR, and I was new to covering
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |